文献速递抗菌药物管理特殊人群用药

急诊与基层医疗中儿童上呼吸道感染β-内酰胺类抗菌药物剂量评估

Evaluating pediatric antimicrobial dosing of β-lactam antibiotics for upper respiratory tract infections in emergency and primary care settings.
PubMed 文献 · Am J Health Syst Pharm · 2025-01-01

该回顾性队列研究在2个急诊科和20个家庭医学门诊评估了200例接受口服β-内酰胺类混悬剂治疗链球菌性咽炎或中耳炎的患儿。32%的处方剂量与最佳实践指南不一致,咽炎错误率高于中耳炎(47% vs 17%,P<0.001)。咽炎错误以超剂量为主,多发生于体重超过20 kg(与剂量上限相关)的患儿;中耳炎错误均为剂量不足。

要点

  • 儿童上呼吸道感染门诊β-内酰胺类混悬剂剂量错误常见,32%与指南不一致。
  • 咽炎剂量错误率47%,显著高于中耳炎的17%(P<0.001)。
  • 体重超过20 kg(与剂量上限相关)的患儿超剂量风险最高。

核心结论

  • 急诊和家庭医学门诊中,儿童上呼吸道感染的口服β-内酰胺类剂量错误常见,体重超过剂量上限对应体重的患儿风险最高。

研究设计与样本

  • 回顾性队列研究,纳入2020年6月1日至2023年5月31日在2个急诊科和20个家庭医学门诊接受阿莫西林、阿莫西林/克拉维酸、头孢地尼或头孢氨苄口服混悬剂治疗链球菌性咽炎或中耳炎的患儿200例。

主要发现

  • 200例中咽炎和中耳炎各100例,32%的β-内酰胺类处方剂量与最佳实践指南不一致。
  • 咽炎剂量错误率47%,中耳炎17%,差异有统计学意义(P<0.001)。
  • 咽炎错误中93.6%为超剂量,其中80.9%发生于体重超过20 kg(与剂量上限相关)的患儿。
  • 中耳炎剂量不适宜的患儿均为剂量不足。

关键数值与推荐

  • 剂量依据适应证特异性最佳实践指南评估一致性,具体推荐数值原文未报告。

临床怎么用

  • 在急诊和家庭医学门诊开具儿童上呼吸道感染β-内酰胺类混悬剂时,应依据适应证指南核对剂量,尤其关注体重超过剂量上限对应体重的患儿。
  • 抗菌药物管理干预应针对处方开具环节,以减少剂量错误。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

PURPOSE: Pediatric prescribing is often weight and indication specific and has been associated with high rates of error. The aim of this study was to evaluate outpatient β-lactam suspension dosing practices for pediatric upper respiratory tract infections (URIs), to characterize the rate of error and to describe common error types. METHODS: This retrospective cohort study was conducted at a community health system with 2 emergency departments and 20 outpatient family medicine practices. Pediatric patients treated from these settings with oral suspension formulations of amoxicillin, amoxicillin/clavulanate, cefdinir, or cephalexin for streptococcal pharyngitis or otitis media between June 1, 2020, and May 31, 2023, were eligible for inclusion. Doses were evaluated against indication-specific best-practice guidelines and assessed for guideline concordance. RESULTS: Of the 200 patients evaluated, 100 were treated for streptococcal pharyngitis and 100 were treated for otitis media. Of the prescribed β-lactam doses, 32% were discordant with best-practice guideline recommendations. Dosing errors were more common for pharyngitis than for otitis media (47% vs 17%; P < 0.001). Overdosing was the most frequently observed error in pharyngitis prescriptions (93.6% of errors) and most commonly occurred in patients weighing more than the 20-kg weight associated with the dosing maximum (80.9% of overdosing errors). All patients receiving an inappropriate dose for otitis media were underdosed. CONCLUSION: Outpatient pediatric dosing errors for URI indications are common among both emergency medicine and family medicine prescribers. Patients weighing over the weight corresponding to the dosing maximum are at highest risk for error. Antimicrobial stewardship interventions targeting the point of prescribing are urgently needed to provide safe dosing practices for pediatric patients.

来源:Am J Health Syst Pharm,查看原文。版权归原作者所有。

引用

  1. Blower N, Draper HM, McAlpine T, et al. Evaluating pediatric antimicrobial dosing of β-lactam antibiotics for upper respiratory tract infections in emergency and primary care settings. Am J Health Syst Pharm. 2025. PMID: 39520672. doi:10.1093/ajhp/zxae343

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。